Cargando…
Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy
Hyposalivation and sensation of dry mouth (xerostomia) are one of the most common adverse effects in the treatment of patients with head and neck cancer. OBJECTIVE: This study evaluates the prevalence of late hyposalivation and associated factors in survivors of squamous cell carcinoma of the oral c...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculdade De Odontologia De Bauru - USP
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075291/ https://www.ncbi.nlm.nih.gov/pubmed/33886946 http://dx.doi.org/10.1590/1678-7757-2020-0854 |
_version_ | 1783684514291122176 |
---|---|
author | Schulz, Riéli Elis Bonzanini, Laura Izabel Lampert Ortigara, Gabriela Barbieri Soldera, Eloisa Barbieri Danesi, Cristiane Cademartori Antoniazzi, Raquel Pippi Ferrazzo, Kívia Linhares |
author_facet | Schulz, Riéli Elis Bonzanini, Laura Izabel Lampert Ortigara, Gabriela Barbieri Soldera, Eloisa Barbieri Danesi, Cristiane Cademartori Antoniazzi, Raquel Pippi Ferrazzo, Kívia Linhares |
author_sort | Schulz, Riéli Elis |
collection | PubMed |
description | Hyposalivation and sensation of dry mouth (xerostomia) are one of the most common adverse effects in the treatment of patients with head and neck cancer. OBJECTIVE: This study evaluates the prevalence of late hyposalivation and associated factors in survivors of squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx treated with radiotherapy with or without concomitant chemotherapy. METHODOLOGY: A cross-sectional study was conducted with 88 patients who had concluded radiotherapy at least three months before the study, at a referral center for the treatment of head and neck cancer in the Southern region of Brazil. Hyposalivation was evaluated based on the stimulated salivary flow rate using the spitting method. Multivariate analysis using binary logistic regression was performed to determine the associations between hyposalivation and clinical and demographic variables. RESULTS: Hyposalivation was found in 78.41% of the sample and the mean radiation dose was 63.01 Gy (±9.58). In the crude model of the multivariate analysis, hyposalivation was associated with higher doses of radiation (p=0.038), treatment with concomitant radiotherapy and chemotherapy (p=0.005), and time elapsed since the end of radiotherapy (p=0.025). In the adjusted model of the multivariate analysis, hyposalivation was only associated with dose and time elapsed. Patient who received higher doses of radiation had a 4.25-fold greater chance of presenting hyposalivation, whereas a longer time elapsed since the end of radiotherapy exerted a 75% protective effect against the occurrence of hyposalivation. CONCLUSION: Hyposalivation is a highly prevalence late-onset side effect of radiotherapy in patients treated for head and neck cancer, with a greater chance of occurrence among those who received higher doses of radiation and those who ended therapy less than 22 months before our study. Concomitant chemotherapy and radiotherapy does not seem to increase the chances of hyposalivation compared to radiotherapy alone. |
format | Online Article Text |
id | pubmed-8075291 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Faculdade De Odontologia De Bauru - USP |
record_format | MEDLINE/PubMed |
spelling | pubmed-80752912021-04-30 Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy Schulz, Riéli Elis Bonzanini, Laura Izabel Lampert Ortigara, Gabriela Barbieri Soldera, Eloisa Barbieri Danesi, Cristiane Cademartori Antoniazzi, Raquel Pippi Ferrazzo, Kívia Linhares J Appl Oral Sci Original Article Hyposalivation and sensation of dry mouth (xerostomia) are one of the most common adverse effects in the treatment of patients with head and neck cancer. OBJECTIVE: This study evaluates the prevalence of late hyposalivation and associated factors in survivors of squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx treated with radiotherapy with or without concomitant chemotherapy. METHODOLOGY: A cross-sectional study was conducted with 88 patients who had concluded radiotherapy at least three months before the study, at a referral center for the treatment of head and neck cancer in the Southern region of Brazil. Hyposalivation was evaluated based on the stimulated salivary flow rate using the spitting method. Multivariate analysis using binary logistic regression was performed to determine the associations between hyposalivation and clinical and demographic variables. RESULTS: Hyposalivation was found in 78.41% of the sample and the mean radiation dose was 63.01 Gy (±9.58). In the crude model of the multivariate analysis, hyposalivation was associated with higher doses of radiation (p=0.038), treatment with concomitant radiotherapy and chemotherapy (p=0.005), and time elapsed since the end of radiotherapy (p=0.025). In the adjusted model of the multivariate analysis, hyposalivation was only associated with dose and time elapsed. Patient who received higher doses of radiation had a 4.25-fold greater chance of presenting hyposalivation, whereas a longer time elapsed since the end of radiotherapy exerted a 75% protective effect against the occurrence of hyposalivation. CONCLUSION: Hyposalivation is a highly prevalence late-onset side effect of radiotherapy in patients treated for head and neck cancer, with a greater chance of occurrence among those who received higher doses of radiation and those who ended therapy less than 22 months before our study. Concomitant chemotherapy and radiotherapy does not seem to increase the chances of hyposalivation compared to radiotherapy alone. Faculdade De Odontologia De Bauru - USP 2021-04-19 /pmc/articles/PMC8075291/ /pubmed/33886946 http://dx.doi.org/10.1590/1678-7757-2020-0854 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Schulz, Riéli Elis Bonzanini, Laura Izabel Lampert Ortigara, Gabriela Barbieri Soldera, Eloisa Barbieri Danesi, Cristiane Cademartori Antoniazzi, Raquel Pippi Ferrazzo, Kívia Linhares Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy |
title | Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy |
title_full | Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy |
title_fullStr | Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy |
title_full_unstemmed | Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy |
title_short | Prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy |
title_sort | prevalence of hyposalivation and associated factors in survivors of head and neck cancer treated with radiotherapy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075291/ https://www.ncbi.nlm.nih.gov/pubmed/33886946 http://dx.doi.org/10.1590/1678-7757-2020-0854 |
work_keys_str_mv | AT schulzrielielis prevalenceofhyposalivationandassociatedfactorsinsurvivorsofheadandneckcancertreatedwithradiotherapy AT bonzaninilauraizabellampert prevalenceofhyposalivationandassociatedfactorsinsurvivorsofheadandneckcancertreatedwithradiotherapy AT ortigaragabrielabarbieri prevalenceofhyposalivationandassociatedfactorsinsurvivorsofheadandneckcancertreatedwithradiotherapy AT solderaeloisabarbieri prevalenceofhyposalivationandassociatedfactorsinsurvivorsofheadandneckcancertreatedwithradiotherapy AT danesicristianecademartori prevalenceofhyposalivationandassociatedfactorsinsurvivorsofheadandneckcancertreatedwithradiotherapy AT antoniazziraquelpippi prevalenceofhyposalivationandassociatedfactorsinsurvivorsofheadandneckcancertreatedwithradiotherapy AT ferrazzokivialinhares prevalenceofhyposalivationandassociatedfactorsinsurvivorsofheadandneckcancertreatedwithradiotherapy |